Clinical Trial Update: Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing Acular LS (ketorolac tromethamine) and Nevanac (nepafenac) for postoperative inflammation after cataract surgery has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• ACULAR LS (Ketorolac tromethamine)
• Nevanac (nepafenac)

Snippet

Sponsor: Innovative Medical | Conditions: Cataract | Phase 4 | Status: COMPLETED